Selected Factor Relating to Fear of Illness Progression among Patients with First Diagnosis of Acute Myocardial Infarction

Main Article Content

Utaiwan Pattamanuch
Rapin Polsook


The objective of this descriptive correlational research was to identify factors related to fear of illness progression among patients with first diagnosing of acute myocardial infarction. A multiple – stage sampling of 213 patients with first diagnosis of acute myocardial infarction were recruited from cardiovascular outpatients department after discharge from Police General Hospital, King Chulalongkorn Memorial Hospital and Siriraj Hospital. Data were collected using sis questionnaires for patient with first diagnosis of acute myocardial infarction: 1) Demographic data form, 2) Perceived chest pain questionnaire, 3) Coronary Artery Disease Education Questionnaire short version, 4) Social support questionnaire, 5) Self – efficacy questionnaire, and 6) Fear of illness progression questionnaire – Short Form. All questionnaire were tested for their content validity by five experts. Test – retest reliability was .99, KR-20 was .71 and Cronbach’s alpha coefficient were .89, .88, and .89 respectively. Data were analyzed using Pearson’s product correlation coefficient statistics. The findings were presented as follow:

  1. 1. Mean score of social support among patients with first diagnosing of acute myocardial infarction was at high level (Mean = 62.54, SD = 11.74). Mean score of severity of illness, knowledge, self – efficacy, and fear of illness progress were at moderate level (Mean = 11.36, SD = 5.67; Mean = 11.34, SD = 3.49; Mean = 31.52, SD = 7.31, and Mean = 26.93, SD = 10.22, respectively).

  2. 2. Self – efficacy was significantly negatively correlated with fear of illness progression among patients with first diagnosing of acute myocardial infarction at the .05 (r = -.367).


Download data is not yet available.

Article Details

Research Article


Sitthisook S. Guideline for ischemic heart disease 2014. 2nd ed. Bangkok: Sri Mueang Printing; 2557. p. 72. (in Thai).

Srivanichakorn S. Morbidity and mortality situation of non - communicable diseases (diabetes type 2 and cardiovascular disease) in Thailand during 2010 - 2014. Disease Control Journal 2017;43(4):379-90. (in Thai).

Allen G. The effect of fear on myocardial infarction patients in intensive care units. [Dissertation]. University of Alabama at Birmingham, School of Nursing; 1998.

Jackson D, Daly J, Davidson P, Elliott D, Cameron-Traub E, Wade V, et al. Women recovering from first-time myocardial infarction (MI): a feminist qualitative study. Journal of Advanced Nursing 2000;32(6):1403-11.

Stevens S, Thomas SP. Recovery of midlife women from myocardial infarction. Health Care For Women International 2012;33(12):1096-113.

Fait K, Vilchinsky N, Dekel R, Levi N, Hod H, Matetzky S. Cardiac-disease-induced PTSD and Fear of illness progression: capturing the unique nature of disease-related PTSD. General Hospital Psychiatry 2018;53:131-8.

Mehnert A, Herschbach P, Berg P, Henrich G, Koch U. Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF). Zeitschrift fur Psychosomatische Medizin und Psychotherapie 2006;52(3):274-88.

Heather I-S, Christi D, Malcolm C, Catherine M, Linda M. The experiences of myocardial infarction patients readmitted within six months of primary percutaneous coronary intervention. Journal of Clinical Nursing 2017;26(21-22):3511-8.

Herschbach P, Dinkel A. Fear of progression. Psycho-Oncology: New York: Springer; 2014. p. 11-29.

Messerli-Bürgy N, Molloy GJ, Poole L, Wikman A, Kaski JC, Steptoe A. Psychological coping and recurrent major adverse cardiac events following acute coronary syndrome. The British Journal of Psychiatry 2015;207(3):256-61.

Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nature Reviews Cardiology 2018;15(4):215.

Phromsont W, Aungsuroch Y, Polsook R. Factors predicting depression among post-acute myocardial infarction patients. Royal Thai Navy Medical Journal 2019;46(3):592-606. (in Thai).

Yang Y, Sun H, Liu T, Zhang J, Wang H, Liang W, et al. Factors associated with fear of progression in chinese cancer patients: sociodemographic, clinical and psychological variables. Journal of Psychosomatic Research 2018;114:18-24.

Shim E-J, Lee JW, Min YH. Does depression decrease the moderating effect of self-efficacy in the relationship between illness perception and fear of progression in breast cancer? Psycho-Oncology 2018;27(2):539-47.

Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, et al. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU International 2016;117(3):469-77.

Ghojazadeh M, Taghizadeh M, Abdi S, Azami-Aghdash S, Andalib S, Farhoudi M. Fear of disease progression in patients with multiple sclerosis: associations of anxiety, depression, quality of life, social support and knowledge. Journal of Clinical Research & Governance 2014;3(2):141-6.

Dunkley S, Siefers R, Tagney J. 101 All patients immediately post primary percutaneous coronary intervention (PPCI) are cared for in an acute cardiac care environment, Is it about time we reviewed our practice?: BMJ Publishing Group Ltd and British Cardiovascular Society; 2016.

Custers JA, de Laat P, Koene S, Smeitink J, Janssen MC, Verhaak C. Fear of disease progression in carriers of the m. 3243A> G mutation. Orphanet Journal of Rare Diseases 2018;13(1):203.

Office of the Royal Society. Body of knowledge-knowledge-knowledge management (km) 2015. [Internet]. [cited 2021 May 12]. Available from: (in Thai).

Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. Journal of Personality Assessment 1988;52(1):30-41.

Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychological Review 1977;84(2):191.

Kang Y, Yang IS. Cardiac self‐efficacy and its predictors in patients with coronary artery diseases. Journal of Clinical Nursing 2013;22(17-18):2465-73.

Cohen J. Statistical power analysis for the behavioral sciences: New York: Academic Press; 2013.

Nilpruk U, Jitpanya C, Polsook R. A study of post - traumatic stress in patients after acute myocardial infarction. Royal Thai Navy Medical Journal 2018;45(2):289-310. (in Thai).

Ghisi GLdM, Sandison N, Oh P. Development, pilot testing and psychometric validation of a short version of the coronary artery disease education questionnaire: The CADE-Q SV. Patient Education and Counseling 2016;99(3):443-7.

Dhamani K, Richter M. Translation of research instruments: research processes, pitfalls and challenges. Africa Journal of Nursing and Midwifery 2011;13(1):3-13.

Wongpakarun N, Wongpakarun T. A revised Thai multi-dimensional scale of perceived social support. The Spanish Journal of Psychology 2012;15(3):1503-9.

Sullivan MD, Lacroix AZ, Russo J, Katon WJ. Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosomatic Medicine 1998;60(4):473-8.

Olanwat K. Selected factors related to depression in patients with acute coronary syndrome, general hospital. [Master's Thesis, Faculty of Nursing]. Chulalongkorn University; 2018. (in Thai).

Wongkuan D. Factors predicting sleep disturbances in acute myocardial infarction survivors. [Master's Thesis, Faculty of Nursing]. Chulalongkorn University; 2017. (in Thai).

Grove SK, Burns N, Gray J. The practice of nursing research: appraisal, synthesis, and generation of evidence. St. Louis: Elsevier Health Sciences; 2012.

Vosbergen S, Janzen J, Stappers PJ, van Zwieten MC, Lacroix J, Idema K, et al. A qualitative participatory study to identify experiences of coronary heart disease patients to support the development of online self-management services. International Journal of Medical Informatics 2013;82(12):1183-94.

Peterson JC, Allegrante JP, Pirraglia PA, Robbins L, Lane KP, Boschert KA, et al. Living with heart disease after angioplasty: a qualitative study of patients who have been successful or unsuccessful in multiple behavior change. Heart & Lung 2010;39(2):105-15.

Sriphet K, Seneha C, Sriprasong S, Kanoksilp A. Factors influencing antiplatelet therapy adherence among patients with acute ST-elevation myocardial infarction in post percutaneous coronary intervention. Thai Journal of Cardio-Thoracic Nursing 2019;30(2):111-25. (in Thai).

Hall DL, Lennes IT, Pirl WF, Friedman ER, Park ER. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Supportive Care in Cancer 2017;25(5):1401-7.

Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, et al. Fear of cancer progression in patients with stage IA malignant melanoma. European Journal of Cancer Care 2018;27(5):e12901.

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, et al. Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter? Health Psychology 2016;35(12):1329.

Commission OotCS. Royal decree on medical benefit money 2010. [Internet]. [cited 2021 March 3]. Available from: (in Thai).

Melchior H, Büscher C, Thorenz A, Grochocka A, Koch U, Watzke B. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer. Psycho-Oncology 2013;22(1):39-45.